Giovine Salvatore 4
4 · Xilio Therapeutics, Inc. · Filed Feb 24, 2022
Insider Transaction Report
Form 4
Giovine Salvatore
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2022-02-22+49,500→ 49,500 totalExercise: $12.66Exp: 2032-02-21→ Common Stock (49,500 underlying)
Footnotes (1)
- [F1]The option award was granted on February 22, 2022 and shall vest on March 1, 2022 with respect to 1/48th of the shares of common stock underlying the stock option and continue to vest in equal monthly installments thereafter until February 1, 2026.